Delivery Order SPE2DB22D2206-SPE2DB23FHT77
Award Date 6/20/23
Potential Completion Date 6/21/23
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $15,126.15 to supply 100 tablets of the pharmaceutical CELLCEPT 500 MG. Performance will take place in Conshohocken, Pennsylvania over one day from August 31st to September 1st, 2023. As a leading provider of pharmaceuticals and healthcare value-added services to the Department of Defense, Amerisourcebergen will fulfill this order from its Corporate Office Division to support the...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $7,768.92 firm fixed price delivery order contract to supply 100 tablets of Cellcept 500 mg to a location in Conshohocken, Pennsylvania. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the Defense Logistics Agency by August 3, 2023 to support the agency's medical supply needs. No subcontractors or set aside designations were indicated. The single delivery...
- The Defense Logistics Agency awarded a $14,353.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500 count) on May 30, 2025, with completion scheduled for June 2, 2025. This delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency Troop Support Medical awarded a $3,306.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 tablets of CELLCEPT 500 MG. The delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania, with all items to be delivered between June 30 and July 3, 2023. No subcontractors or set aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively awarded delivery order (Contract No. 4568982464) by the Defense Logistics Agency on August 4, 2025, for the supply of CellCept 500 mg tablets in a quantity of 100 units. This firm fixed-price delivery order carries a ceiling value of $7,817.19 and is scheduled for ultimate completion by August 5, 2025. The contract carries no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $27,735.62 and carries no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $33,203.38 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count units). This competitive, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract does not carry a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on July 16, 2025, for CellCept 250 mg capsules (100-count units) with a ceiling value of $17,152.58. This firm fixed-price delivery order, which is due for completion by July 17, 2025, represents a non-set-aside competitive award under the broader pharmaceutical supply framework. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of CellCept 500 mg tablets (100-count units) valued at $7,015.33. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of CellCept 500 mg tablets (500-count) with a contract ceiling value of $20,432.36. This firm fixed-price delivery order, with an ultimate completion date of July 2, 2025, represents a non-set-aside competitive award under AmerisourceBergen's broader federal contract portfolio. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FHT77Delivery Order
The Defense Logistics Agency awarded a $15,369.82 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 tablets of CELLCEPT 500 MG. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with performance spanning June 20-21, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the immunosuppressant drug to support DLA's medical supply chain requirements. No subcontractors or set aside designations were indicated. The brief period of performance suggests this delivery order was placed to meet an immediate, non-stocked item need.
Generated 12/18/23, 8:32 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 6/20/23 |